EGCG can also attenuate the growth of hepatocellular carcinoma cells by inhibiting the IGF-1/IGF-1R axis and ERK, AKT, STAT3, and GSK3β signals [124]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.